Cargando…
DNA Nanotechnology for Cancer Diagnosis and Therapy
Cancer is one of the leading causes of mortality worldwide, because of the lack of accurate diagnostic tools for the early stages of cancer. Thus, early diagnosis, which provides important information for a timely therapy of cancer, is of great significance for controlling the development of the dis...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032219/ https://www.ncbi.nlm.nih.gov/pubmed/29874867 http://dx.doi.org/10.3390/ijms19061671 |
_version_ | 1783337463440211968 |
---|---|
author | Chen, Tianshu Ren, Lingjie Liu, Xiaohao Zhou, Mengru Li, Lingling Xu, Jingjing Zhu, Xiaoli |
author_facet | Chen, Tianshu Ren, Lingjie Liu, Xiaohao Zhou, Mengru Li, Lingling Xu, Jingjing Zhu, Xiaoli |
author_sort | Chen, Tianshu |
collection | PubMed |
description | Cancer is one of the leading causes of mortality worldwide, because of the lack of accurate diagnostic tools for the early stages of cancer. Thus, early diagnosis, which provides important information for a timely therapy of cancer, is of great significance for controlling the development of the disease and the proliferation of cancer cells and for improving the survival rates of patients. To achieve the goals of early diagnosis and timely therapy of cancer, DNA nanotechnology may be effective, since it has emerged as a valid technique for the fabrication of various nanoscale structures and devices. The resultant DNA-based nanoscale structures and devices show extraordinary performance in cancer diagnosis, owing to their predictable secondary structures, small sizes, and high biocompatibility and programmability. In particular, the rapid development of DNA nanotechnologies, such as molecular assembly technologies, endows DNA-based nanomaterials with more functionalization and intellectualization. Here, we summarize recent progress made in the development of DNA nanotechnology for the fabrication of functional and intelligent nanomaterials and highlight the prospects of this technology in cancer diagnosis and therapy. |
format | Online Article Text |
id | pubmed-6032219 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60322192018-07-13 DNA Nanotechnology for Cancer Diagnosis and Therapy Chen, Tianshu Ren, Lingjie Liu, Xiaohao Zhou, Mengru Li, Lingling Xu, Jingjing Zhu, Xiaoli Int J Mol Sci Review Cancer is one of the leading causes of mortality worldwide, because of the lack of accurate diagnostic tools for the early stages of cancer. Thus, early diagnosis, which provides important information for a timely therapy of cancer, is of great significance for controlling the development of the disease and the proliferation of cancer cells and for improving the survival rates of patients. To achieve the goals of early diagnosis and timely therapy of cancer, DNA nanotechnology may be effective, since it has emerged as a valid technique for the fabrication of various nanoscale structures and devices. The resultant DNA-based nanoscale structures and devices show extraordinary performance in cancer diagnosis, owing to their predictable secondary structures, small sizes, and high biocompatibility and programmability. In particular, the rapid development of DNA nanotechnologies, such as molecular assembly technologies, endows DNA-based nanomaterials with more functionalization and intellectualization. Here, we summarize recent progress made in the development of DNA nanotechnology for the fabrication of functional and intelligent nanomaterials and highlight the prospects of this technology in cancer diagnosis and therapy. MDPI 2018-06-05 /pmc/articles/PMC6032219/ /pubmed/29874867 http://dx.doi.org/10.3390/ijms19061671 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Chen, Tianshu Ren, Lingjie Liu, Xiaohao Zhou, Mengru Li, Lingling Xu, Jingjing Zhu, Xiaoli DNA Nanotechnology for Cancer Diagnosis and Therapy |
title | DNA Nanotechnology for Cancer Diagnosis and Therapy |
title_full | DNA Nanotechnology for Cancer Diagnosis and Therapy |
title_fullStr | DNA Nanotechnology for Cancer Diagnosis and Therapy |
title_full_unstemmed | DNA Nanotechnology for Cancer Diagnosis and Therapy |
title_short | DNA Nanotechnology for Cancer Diagnosis and Therapy |
title_sort | dna nanotechnology for cancer diagnosis and therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032219/ https://www.ncbi.nlm.nih.gov/pubmed/29874867 http://dx.doi.org/10.3390/ijms19061671 |
work_keys_str_mv | AT chentianshu dnananotechnologyforcancerdiagnosisandtherapy AT renlingjie dnananotechnologyforcancerdiagnosisandtherapy AT liuxiaohao dnananotechnologyforcancerdiagnosisandtherapy AT zhoumengru dnananotechnologyforcancerdiagnosisandtherapy AT lilingling dnananotechnologyforcancerdiagnosisandtherapy AT xujingjing dnananotechnologyforcancerdiagnosisandtherapy AT zhuxiaoli dnananotechnologyforcancerdiagnosisandtherapy |